Anna studied Biology, with an emphasis on Cell, Molecular and Developmental Biology at the University of Crete, Greece. During her PhD in Queen Mary, University of London she worked on the knockout of Flavin-containing monoxygenase 5 (Fmo5) gene of the mouse, which eventually led to the identification of Fmo5 as a regulator of metabolic aging. As a Postdoc at the Universities of Ioannina, Greece and the University of Cambridge, UK she worked on the role of cell-surface receptors (Wnt/Notch/FGF4) and adherens junctions in the fate specification of mouse embryonic stem (mES) cells and mES-derived multipotent cardiac progenitors. She also worked in the development of an ES-cell-based expression and reporting system for the identification of functional antibodies that control stem cell differentiation from antigen-binding populations preselected with phage display. Anna joined the BMC series as a Manuscript editor March 2019, making decisions in a wide range of medical and biological journals. In 2021 she became a Senior editor and the Lead Editor of BMC Cardiovascular Disorders and BMC Endocrine Disorders until 2022, when she joined BMC Biology. Anna primarily handles manuscripts in the areas of Cell and Developmental Biology and has a keen interest in Stem Cell Biology and Regeneration.